Argenx Se (ARGX) Non-Current Deferred Tax Liability (2020 - 2024)

Argenx Se (ARGX) posted Non-Current Deferred Tax Liability of $5.0 million for Q2 2024, down 3.12% on a QoQ basis from $5.2 million in Q4 2023, and down 43.85% year-over-year from $8.9 million in Q3 2023.

Argenx Se (ARGX) Non-Current Deferred Tax Liability (2020 - 2024) Analysis & Trends

Argenx Se's Non-Current Deferred Tax Liability history runs 5 years deep, the most recent figure standing at $5.0 million for Q2 2024.

  • Quarterly Non-Current Deferred Tax Liability fell 43.85% year-over-year to $5.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $5.0 million (down 43.85% YoY) and the FY2023 annual result came in at $5.2 million, down 38.67% from the prior year.
  • Non-Current Deferred Tax Liability was $5.0 million for Q2 2024 at Argenx Se, down from $5.2 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $12.4 million in Q2 2021 and bottomed at $959371.8 in Q2 2020.
  • A 5-year average of $6.3 million and a median of $6.4 million in 2021 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2021 — Non-Current Deferred Tax Liability soared 1191.26% — and 2024, when it plunged 43.85%.
  • Argenx Se's Non-Current Deferred Tax Liability stood at $1.4 million in 2020, then soared by 345.52% to $6.4 million in 2021, then soared by 30.57% to $8.4 million in 2022, then plunged by 38.67% to $5.2 million in 2023, then declined by 3.12% to $5.0 million in 2024.
  • Business Quant data shows ARGX's Non-Current Deferred Tax Liability at $5.0 million in Q2 2024, $5.2 million in Q4 2023, and $8.9 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 4.99 Mn
Jun 30, 2024 4.99 Mn
Dec 31, 2023 5.16 Mn
Dec 31, 2023 5.16 Mn
Jun 30, 2023 8.89 Mn
Jun 30, 2023 8.89 Mn
Dec 31, 2022 8.41 Mn
Dec 31, 2022 8.41 Mn
Jun 30, 2022 7.66 Mn
Jun 30, 2022 7.66 Mn
Dec 31, 2021 6.44 Mn
Dec 31, 2021 6.44 Mn
Jun 30, 2021 12.39 Mn
Jun 30, 2021 12.39 Mn
Dec 31, 2020 1.45 Mn
Dec 31, 2020 1.45 Mn
Jun 30, 2020 959,371.77
Jun 30, 2020 959,371.77